← Back to Search

Cognitive Behavioral Therapy

Cognitive Behavioral Therapy for Suicidal Thoughts in Physical Disabilities

N/A
Recruiting
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age
Past-week suicidal ideation or past-month suicide attempt
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through treatment completion, an average of 3 months
Awards & highlights

Study Summary

This trial looks at how a therapy can help reduce suicidal thoughts & attempts in people with physical disabilities.

Who is the study for?
This trial is for adults with physical disabilities affecting vision, hearing, or mobility who have had suicidal thoughts in the past week or a suicide attempt in the past month. Participants must be able to give informed consent and need internet access with a webcam.Check my eligibility
What is being tested?
The study tests Brief Cognitive Behavioral Therapy aimed at reducing suicidal thoughts and attempts among people with physical disabilities. It's a psychotherapy approach that does not involve medication.See study design
What are the potential side effects?
Since this intervention involves therapy rather than medication, typical medical side effects are not expected. However, discussing sensitive topics may cause emotional discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have thought about suicide in the last week or attempted it in the last month.
Select...
I have a disability that affects my vision, hearing, or ability to move.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through treatment completion, an average of 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through treatment completion, an average of 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Scaler for Suicide Ideation
Secondary outcome measures
Self-Injurious Thoughts and Behaviors Interview-Revised

Trial Design

1Treatment groups
Experimental Treatment
Group I: Brief Cognitive Behavioral Therapy for People with Physical DisabilitiesExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

American Foundation for Suicide PreventionOTHER
32 Previous Clinical Trials
9,669 Total Patients Enrolled
Ohio State UniversityLead Sponsor
823 Previous Clinical Trials
501,183 Total Patients Enrolled

Media Library

Brief Cognitive Behavioral Therapy for People with Physical Disabilities (Cognitive Behavioral Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05695430 — N/A
Visual Impairment Research Study Groups: Brief Cognitive Behavioral Therapy for People with Physical Disabilities
Visual Impairment Clinical Trial 2023: Brief Cognitive Behavioral Therapy for People with Physical Disabilities Highlights & Side Effects. Trial Name: NCT05695430 — N/A
Brief Cognitive Behavioral Therapy for People with Physical Disabilities (Cognitive Behavioral Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05695430 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers still recruiting volunteers for this experiment?

"Data listed on clinicaltrials.gov affirms that this medical experiment is still recruiting participants. The trial was initially opened to the public on March 1st 2022 and underwent its last update approximately one year later, in December of 2023."

Answered by AI

To what ceiling has the number of trial participants been capped?

"Yes, the data hosted on clinicaltrials.gov confirms that this medical experiment is actively enrolling individuals. It was first posted in March 1st 2022 and updated last December 1st 2023. A total of 60 participants from a single trial site are required for successful completion of the study."

Answered by AI
~17 spots leftby Feb 2025